Valentina Arena

6PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematological tumoursPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.

Renato Bassan, Sabina Chiaretti, Irene Della Starza

|Jul 05, 2024
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial.

Adriano Venditti, Alfonso Piciocchi, Anna Candoni

|Dec 19, 2022
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.

Sabina Chiaretti, Akram Taherinasab, Irene Della Starza

|Aug 01, 2022
Childhood acute promyelocytic leukemia in a pediatric cancer referral center in Baghdad, Iraq. Improved results with ATRA extended consolidation.

Anna Maria Testi, Mazin Faisal Al-Jadiry, Hasanein Habeeb Ghali

|Nov 03, 2021
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.

Francesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi

|Sep 29, 2021
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.

Gian Matteo Rigolin, Ilaria Del Giudice, Antonella Bardi

Pageof 1

Frequent Collaborators

5 joint publications

Alfonso Piciocchi

2 joint publications

Adriano Venditti

2 joint publications

Maria Teresa Voso

2 joint publications

Francesco Albano